You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘clopidogrel’
May 2009
Br J Cardiol 2009;16:121-125
News from the 58th Annual Scientific Session of the American College of Cardiology
The 2009 American College of Cardiology (ACC) meeting was held in Orlando, US, from March 29th–31st 2009. Highlights this year included the first major results
November 2008
Br J Cardiol 2008;15:307-11
South East London Cardiac Prescribing Forum: working to improve clopidogrel prescribing across the South East London sector
National guidance recommends specific durations for clopidogrel and aspirin dual therapy post ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI) and following percutaneous
September 2007
Br J Cardiol 2007;14:194-99
News from the 2007 Congress of the European Society of Cardiology
ADVANCE – lowering blood pressure reduces events in diabetes
Death rates with drug-eluting stents worse in STEMI patients
Women with ACS do worse with PCI
EUROASPIRE: lifestyle issues
July 2006
Br J Cardiol 2006;13:284-86
Should acute MI patients receive dual antiplatelet therapy: a review of new data
Thrombolytic therapy in the management of acute myocardial infarction (MI) shows true evidence of benefit. Administration of a thrombolytic saves about 30 lives per 1,000
March 2006
Br J Cardiol (Acute Interv Cardiol) 2006;13:AIC 5–AIC 8
Bivalirudin, abciximab and clopidogrel in modern PCI: interpretation and experience from King’s College Hospital
Platelet inhibition is a prerequisite for successful percutaneous coronary interventions (PCI). Aspirin was the first antiplatelet agent with proven benefit in ST-elevation infarction (STEMI) in
March 2006
Br J Cardiol 2006;13:90-8
American College of Cardiology 55th Annual Scientific Session
The ASTEROID trial, which showed regression of atherosclerosis by reducing low-density lipoprotein cholesterol to new lows and simultaneously improving high-density lipoprotein cholesterol, was one of
January 2005
Br J Cardiol 2005;12:57-60
Antiplatelet therapy for stroke prevention
Antiplatelet therapy plays a major role in the secondary prevention of ischaemic stroke. The antiplatelet agents that are most used in the clinic include aspirin,
May 2003
Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 49–AIC 51
Pre-operative strategies on clopidogrel use in coronary artery bypass grafting
There is a lack of standards pertaining to stopping antiplatelet agents in patients with acute coronary syndromes prior to coronary surgery. We conducted a national